Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence-Reference-Cited by-同舟云学术

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence

Published:2012-07 Issue:1 Volume:40 Page:1-8
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Vardakas Konstantinos Z.,Polyzos Konstantinos A.,Patouni Konstantina,Rafailidis Petros I.,Samonis George,Falagas Matthew E.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference54 articles.

1. Clinical practice. Antibiotic-associated diarrhea;Bartlett;N Engl J Med,2002

2. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea;Kyne;Lancet,2001

3. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity;Pepin;CMAJ,2004

4. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada;Pepin;Clin Infect Dis,2005

5. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee;Fekety;Am J Gastroenterol,1997

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of extracellular structures in Clostridioides difficile biofilm formation;Anaerobe;2024-08

2. Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study;Clinical Microbiology and Infection;2024-08

3. Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile;mSphere;2024-07-30

4. A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

5. A commensal protozoan attenuates Clostridioides difficile pathogenesis in mice via arginine-ornithine metabolism and host intestinal immune response;Nature Communications;2024-04-02